Roberto Tinoco, Ph.D.
Dr. Tinoco was recruited to UCI in 2018 to continue his studies on T cell exhaustion in murine models of melanoma and in chronic viral (LCMV) infection. He discovered an important role for TGF-beta in LCMV, which was produced by virus-specific CD8+ T cells. Dr. Tinoco also identified PSGL1 as a novel immune checkpoint in metastatic melanoma (Immunity 2016). He currently has three TGE students, Julia DeRogatis, Emily Neubert and Karla Viramontes (URM). As URM faculty member, Dr. Tinoco is committed to mentoring diversity trainees.